Free Trial

Titan Pharmaceuticals (TTNP) SEC Filings & 10K Form

$5.54
-0.30 (-5.13%)
(As of 07/26/2024 ET)

Recent Titan Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/26/2024
8:39 AM
Titan Pharmaceuticals (Filer)
Form RW
04/05/2024
3:34 PM
Sire Group Ltd. (Filed by)
Titan Pharmaceuticals (Subject)
Form SC 13D/A
04/05/2024
9:13 AM
Flores Francisco (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/05/2024
9:14 AM
Mokhtar Firdauz (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2024
8:45 AM
Choong Choon Hau (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
11:19 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
3:59 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
4:13 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:30 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:30 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
3:05 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
3:15 PM
Titan Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/26/2023
3:23 PM
Ben-Tzvi Avraham (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
3:25 PM
Beebe Katherine (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
3:29 PM
Greenberg Eric Howard (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
3:31 PM
McMurdo Matthew Charles (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
3:33 PM
NATAN DAVID (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2023
4:26 PM
Titan Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/23/2023
2:07 PM
Chiam Brynner (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2023
4:08 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
4:30 PM
Sire Group Ltd. (Filed by)
Titan Pharmaceuticals (Subject)
Form SC 13D
10/04/2023
3:40 PM
Shen Seow Gim (Reporting)
Sire Group Ltd. (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/19/2023
3:41 PM
Titan Pharmaceuticals (Filer)
Form 8-K/A
09/18/2023
3:45 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2023
4:30 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2023
3:28 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
4:08 PM
Titan Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2023
7:06 PM
Greenberg Eric Howard (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2023
6:42 PM
McMurdo Matthew Charles (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4/A
07/31/2023
6:44 PM
Chasey Peter Louis (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4/A
07/31/2023
6:45 PM
NATAN DAVID (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4/A
07/31/2023
6:38 PM
Ben-Tzvi Avraham (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2023
6:39 PM
Lazar David E. (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
4:42 PM
NATAN DAVID (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
4:43 PM
McMurdo Matthew Charles (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
4:45 PM
Beebe Katherine (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
4:47 PM
Chasey Peter Louis (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TTNP) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners